Use of Rivaroxaban for Prevention of Venous Thromboembolic Complications in Elderly Patients after Hip Arthroplasty-Reference-Cited by-同舟云学术

Use of Rivaroxaban for Prevention of Venous Thromboembolic Complications in Elderly Patients after Hip Arthroplasty

Published:2016-09-30 Issue:3 Volume: Page:74-77
ISSN:0869-8678
Container-title:Vestnik travmatologii i ortopedii imeni N.N. Priorova
language:
Short-container-title:Vestn. travmatol. ortop. im. N.N. Priorova

Author:

Afanas’Ev A. P.¹,Kardanov A. A.²,Karandin A. S.²,Korolev A. V.²

Affiliation:

1. European Clinic of Sports Traumatology and Orthopaedics

2. Peoples' Friendship University of Russia

Abstract

Results of retrospective analysis of the efficacy and safety of venous thromboembolic complications prevention using anticoagulants (low-molecular-weight heparins and rivaroxaban) in elderly (over 75 years) patients after hip arthroplasty are presented. Ninety four patients were divided into 2 groups (n=47) depending on the applied anticoagulant. Follow up period was 6 months after hospitalization. Asymptomatic thrombosis was diagnosed by duplex ultrasonography only in 1 (2.1%) patient from low-molecular-weight heparin group. No one case of either bleeding or hemorrhage was recorded. It is stated that rivaroxaban ensured effective thromboprophylaxis and safety after hip arthroplasty in elderly patients when no restrictions related to the use of low-molecular-weight heparin injections are present.

Publisher

ECO-Vector LLC

Subject

General Medicine

Reference15 articles.

1. Kakkar A.K., Brenner B., Dahl O.E., Eriksson B.I., Mouret P., Muntz J. et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008; 372 (9632): 31–9.

2. Lassen M.R., Ageno W., Borris L.C., Lieberman J.R., Rosencher N., Bandel T.J. et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N. Engl. J. Med. 2008; 358 (26): 2776–86.

3. Torbicki A., Perrier A., Konstantinides S., Agnelli G., Galiè N., Pruszczyk P. et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2008; 29 (18): 2276–2315.

4. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., Colwell C.W. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest J. 2008; 133 (6_suppl.): 381S–453S.

5. Haines S.T. Improving anticoagulant use for prevention of venous thromboembolism. Am. J. Health. Syst. Pharm. 2010; 67 (10 Suppl 6): S2–3.